Pfizer (NYSE: PFE) was found in violation of US racketeering laws by a federal jury in Boston. The suit, brought on by Kaiser Foundation Health Plan, Inc and Kaiser Foundation Hospitals, was decided by jury after two days of deliberation following a month long trial. The drug Neurontin is at the center of the battle […]
$142M Damage Award in Pfizer (NYSE: PFE) Case was created by and is property of American Consumer News.